Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NephroD: Vitamin D3 in CRRT
NCT05657678Phase 4Recruiting
- Sponsor
- Uniwersytecki Szpital Kliniczny w Opolu
- Start
- Dec 2022
- Primary completion
- Jan 2026
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of vitamin d in Vitamin D deficiency (VDD) (2 arms), sponsored by Uniwersytecki Szpital Kliniczny w Opolu. Primary endpoint: Percentage of patients achieving serum 25(OH)D3 levels >= 30 ng/ml at 7 days. Started Dec 2022; status: recruiting.
02
Drugs
vitamin d
03
Conditions
Vitamin D deficiency (VDD)
Beyond the preview
Go deeper on NCT05657678.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05657678.